Lin Elizabeth Yeu, Chief Medical Officer at Tarsus Pharmaceuticals ($TARS), made two open market sales of company shares over the past year, totaling about $207 thousand. Her most recent sale occurred on December 16, 2025. These sales rank her 8,347th among 11,678 insiders in our database by total value sold, well below the average of 8.6 million per insider across an average of 6.4 transactions. She reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | S | Common Stock | 379 | $68.71 | 42,098.0000 | 42,607,717 | 0.89% | 0.00% |
| March 17, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | S | Common Stock | 375 | $69.42 | 42,477.0000 | 42,607,717 | 0.88% | 0.00% |
| March 19, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | S | Common Stock | 390 | $67.00 | 41,708.0000 | 42,607,717 | 0.93% | 0.00% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | M | Common Stock | 2511 | $0.00 | 42,852.0000 | 42,607,717 | 6.22% | 0.01% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | M | Restricted Stock Units | 2511 | $0.00 | 7,534.0000 | 42,607,717 | 25.00% | 0.01% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | A | Restricted Stock Units | 17161 | $0.00 | 17,161.0000 | 42,607,717 | 9999.99% | 0.04% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | A | Stock Option (right to buy) | 27310 | $0.00 | 27,310.0000 | 42,607,717 | 9999.99% | 0.06% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | M | Restricted Stock Units | 6819 | $0.00 | 20,459.0000 | 42,607,717 | 25.00% | 0.02% |
| Dec. 16, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | S | Common Stock | 2078 | $79.50 | 40,341.0000 | 42,607,717 | 4.90% | 0.00% |
| Dec. 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | M | Common Stock | 6819 | $0.00 | 42,419.0000 | 42,607,717 | 19.15% | 0.02% |
| June 18, 2025 | STAAR SURGICAL CO | $STAA | Lin Elizabeth Yeu | Not found | A | Restricted Stock Units | 5341 | $0.00 | 5,341.0000 | 49,125,000 | 9999.99% | 0.01% |
| June 18, 2025 | STAAR SURGICAL CO | $STAA | Lin Elizabeth Yeu | Not found | A | Common Stock Options | 9708 | $0.00 | 9,708.0000 | 49,125,000 | 9999.99% | 0.02% |
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 37,604,538 | 100.00% | 0.01% |
| June 13, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | M | Common Stock | 3350 | $0.00 | 36,606.0000 | 37,604,538 | 10.07% | 0.01% |
| June 16, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | S | Common Stock | 1006 | $41.08 | 35,600.0000 | 37,604,538 | 2.75% | 0.00% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | A | Restricted Stock Units | 10045 | $0.00 | 10,045.0000 | 37,604,538 | 9999.99% | 0.03% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | A | Stock Option (right to buy) | 15314 | $0.00 | 15,314.0000 | 37,604,538 | 9999.99% | 0.04% |
| Nov. 4, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | A | Restricted Stock Units | 27278 | $0.00 | 27,278.0000 | 38,381,968 | 9999.99% | 0.07% |
| Nov. 4, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Chief Medical Officer | A | Stock Option (right to buy) | 41074 | $0.00 | 41,074.0000 | 38,381,968 | 9999.99% | 0.11% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | M | Common Stock | 3350 | $0.00 | 33,256.0000 | 29,383,276 | 11.20% | 0.01% |
| June 24, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | M | Restricted Stock Units | 3350 | $0.00 | 0.0000 | 29,383,276 | 100.00% | 0.01% |
| June 20, 2024 | STAAR SURGICAL CO | $STAA | Lin Elizabeth Yeu | Not found | A | Common Stock | 2244 | $0.00 | 5,099.0000 | 49,427,000 | 78.60% | 0.00% |
| June 20, 2024 | STAAR SURGICAL CO | $STAA | Lin Elizabeth Yeu | Not found | A | Common Stock Options | 4010 | $0.00 | 4,010.0000 | 49,427,000 | 9999.99% | 0.01% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 29,383,276 | 9999.99% | 0.02% |
| June 13, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 29,383,276 | 9999.99% | 0.01% |
| Jan. 25, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 29,383,276 | 9999.99% | 0.03% |
| Aug. 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | P | Common Stock | 9506 | $16.80 | 29,906.0000 | 24,619,700 | 46.60% | 0.04% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | A | Stock Option (right to buy) | 5000 | $0.00 | 5,000.0000 | 24,619,700 | 9999.99% | 0.02% |
| June 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | A | Restricted Stock Units | 3350 | $0.00 | 3,350.0000 | 24,619,700 | 9999.99% | 0.01% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | M | Common Stock | 2000 | $0.00 | 20,400.0000 | 24,619,700 | 10.87% | 0.01% |
| June 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Lin Elizabeth Yeu | Director | M | Restricted Stock Units | 2000 | $0.00 | 0.0000 | 24,619,700 | 100.00% | 0.01% |